Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay Meeting Abstract


Authors: Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; Hamlin, P. A.; Copeland, A. R.; Matasar, M. J.; Sauter, C. S.; Kumar, A.; Noy, A.; Straus, D. J.; Portlock, C. S.; Criscuolo, F.; He, J.; Royston, D.; Balasubramanian, S.; Reznikovskaya, Y.; Pichardo, J. D.; Stephens, P.; Miller, V.; Levine, R. L.; Seshan, V.; Dogan, A.; Younes, A.
Abstract Title: Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368020102180
PROVIDER: wos
Notes: Meeting Abstract: 2668 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos